ES2174384T3 - Composicion farmaceutica estabilizada que contiene dopamina o dobutamina. - Google Patents

Composicion farmaceutica estabilizada que contiene dopamina o dobutamina.

Info

Publication number
ES2174384T3
ES2174384T3 ES98123663T ES98123663T ES2174384T3 ES 2174384 T3 ES2174384 T3 ES 2174384T3 ES 98123663 T ES98123663 T ES 98123663T ES 98123663 T ES98123663 T ES 98123663T ES 2174384 T3 ES2174384 T3 ES 2174384T3
Authority
ES
Spain
Prior art keywords
dobutamine
pharmaceutical composition
composition containing
stabilized pharmaceutical
containing dopamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98123663T
Other languages
English (en)
Inventor
Ingo Dr Bonnacker
Wolfgang Tolke
Martina Lerch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Pharmaceuticals GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of ES2174384T3 publication Critical patent/ES2174384T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBEN NUEVAS COMPOSICIONES FARMACEUTICAS LIQUIDAS Y ACUOSAS QUE ESTAN ESTABILIZADAS, QUE CONTIENE COMO PRINCIPIO ACTIVO EN PARTICULAR DOPAMINA O TAMBIEN DOBUTAMINA QUE SON APROPIADAS PARA INYECTARSE. EN LUGAR DEL ESTABILIZADOR UTILIZADO DE MANERA NORMAL EN EL ESTADO DE LA TECNICA DEL GRUPO LOS SULFITOS (P. E. METABISULFITO DE SODIO) LAS NUEVAS COMPOSICIONES DE LA INVENCION CONTIENEN CISTEINA Y/O UN DERIVADO DE CIESTINA DEL GRUPO DE LAS SALES DE ADICION ACIDA E HIDRATOS.
ES98123663T 1997-12-19 1998-12-11 Composicion farmaceutica estabilizada que contiene dopamina o dobutamina. Expired - Lifetime ES2174384T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19756758A DE19756758C1 (de) 1997-12-19 1997-12-19 Stabilisierte pharmazeutische Zusammensetzung enthaltend Dopamin oder Dobutamin

Publications (1)

Publication Number Publication Date
ES2174384T3 true ES2174384T3 (es) 2002-11-01

Family

ID=7852669

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98123663T Expired - Lifetime ES2174384T3 (es) 1997-12-19 1998-12-11 Composicion farmaceutica estabilizada que contiene dopamina o dobutamina.

Country Status (6)

Country Link
EP (1) EP0925785B1 (es)
AT (1) ATE214917T1 (es)
DE (2) DE19756758C1 (es)
DK (1) DK0925785T3 (es)
ES (1) ES2174384T3 (es)
PT (1) PT925785E (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102085180B (zh) * 2011-01-26 2012-10-10 马鞍山丰原制药有限公司 一种盐酸多巴酚丁胺水针剂及其制备方法
CN117257728B (zh) * 2023-09-18 2026-06-05 遂成药业股份有限公司 一种盐酸多巴胺注射液及其制备方法
WO2025126206A1 (en) * 2023-12-11 2025-06-19 Yeda Research And Development Co. Ltd. Method for synthesizing dopamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070173A1 (en) * 1969-10-29 1971-09-10 Alcon Lab In Stabilized aqs pyrocatecholamine prepns
JPS57188515A (en) * 1981-05-13 1982-11-19 Kyoto Yakuhin Kogyo Kk Stabilized aqueous dopamine preparation
JPS58203910A (ja) * 1982-05-20 1983-11-28 Nikken Kagaku Kk ドパミン含有点滴静注用剤
US5002973A (en) * 1987-12-28 1991-03-26 Dey Laboratories, Inc. Stabilized sulfite-free catecholamine compositions
WO1994013274A1 (en) * 1992-12-10 1994-06-23 Abbott Laboratories Stabilized catecholamine solutions
FR2740337B1 (fr) * 1995-10-27 1997-11-21 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees contenant un derive ayant une activite adrenergique

Also Published As

Publication number Publication date
EP0925785B1 (de) 2002-03-27
DE19756758C1 (de) 1999-08-05
DK0925785T3 (da) 2002-07-01
EP0925785A1 (de) 1999-06-30
DE59803498D1 (de) 2002-05-02
ATE214917T1 (de) 2002-04-15
PT925785E (pt) 2002-07-31

Similar Documents

Publication Publication Date Title
AU628768B2 (en) Stabilized solutions of psychotropic agents
ES2123784T3 (es) Utilizacion en cosmetica de derivados lipofilos de amino-desoxialditoles, composiciones cosmeticas que los contienen, y nuevos carbamatos de alquilo.
BR9911579A (pt) Uso de um composto antimicrobiano para desinfecção
CY1105528T1 (el) Παρασκευaσματα σταθεροποιημeνα για μακρo διaστημα
DK1273299T3 (da) Minoxidilinindeholdende praparater
AR015413A1 (es) Composicion cosmetica util especialmente para el blanqueo de la piel
MX9201313A (es) Composicion oxidante que contiene granulos activadores de blanqueo estables.
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
ES2189657B1 (es) Composiciones de resina plaguicidas.
DE60117467D1 (de) Famotidin-injektionen
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
PT925785E (pt) Composicao farmaceutica estabilizada que contem dopamina ou dobutamina
BR9912706A (pt) Composições farmacêuticas contendo ibuprofeno e domperidona
FR2773067B1 (fr) Composition cosmetique de vernis a base de nitrocellulose contenant un agent stabilisant
ES2046511T3 (es) Para-aminofenoles sustituidos en la posicion 2 y su utilizacion para la tincion de fibras queratinicas.
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
SE8605050D0 (sv) Anvendning av tetrahydrobensotienylkarbamid-derivat som fungicider
PT1140942E (pt) Inibidores da prenil-transferase
GT199900087A (es) Terapia de combinacion para la fragilidad musculoesqueletica.
ES2080917T3 (es) Composiciones antimicrobianas que comprenden compuestos yodopropargilicos e isotiazolonas.
ATE499114T1 (de) Stabilisierte wässrige erythropoietinhaltige arzneizusammensetzungen
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
DE69602208D1 (de) Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
DE69520977D1 (de) Stärkezusammensetzung
ATE275617T1 (de) Aliphatische ester und ihre verwendung als duftstoff

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 925785

Country of ref document: ES